Spots Global Cancer Trial Database for A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
Official Title: A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
Study ID: NCT03735511
Conditions
Interventions
Study Description
Brief Summary: The study was designed to evaluate the efficacy and safety of apatinib in the treatment of patients with gastric carcinoma.
Detailed Description: The study is a real-world non-interventional retrospective study and will collect the original medical records of patients with gastric carcinoma treated with apatinib from 2015 to 2018 in Henan Cancer Hospital. Clinical data such as patient demographic, history of treatments, tumor biological characteristics and adverse events will be analyzed to evaluate the efficacy and safety of apatinib and explore the risk factors of prognosis in patients with gastric carcinoma.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Henan Cancer Hospital, Zhengzhou, Henan, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
